A Review on various promising antivirals for management of COVID 19 & Comparison of Regimens of Antivirals in various Treatment guidelines for Management of Covid-19 across the world

Author : Muhammed Rashid A.K, Jimcy Mathew

An acute respiratory disease, caused by a novel coronavirus SARS-CoV-2 (COVID-19) has spread from Wuhan city of China and received worldwide attention. On 30 January 2020, World Health Organization (WHO) officially declared the COVID-19 as a PANDEMIC. The emergence of SARS-CoV-2, since the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, marked the third introduction of a highly pathogenic and large-scale epidemic coronavirus into the human population in the twenty-first century. In this article, we are discussing about various promising antivirals showing potential effect in COVID 19 management worldwide.

Full Text Attachment

Creative Commons License World Journal of Pharmaceutical Science is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at Permissions beyond the scope of this license may be available at